MYRIAD GENETICS INC — Director's Dealing 2014

Sep 18, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2014-09-17

Reporting Person: McDade Ralph L (President Myriad RBM, Inc.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-09-17	Common Stock	A	32000.0	$0.0	Acquired	32801	Direct

Footnotes

F1: Consists of restricted stock units granted pursuant to the Company's 2010 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% per year over a four-year period on each anniversary of the date of grant.